Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment 2016-10-17
  2. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease 2014-04-14
  3. Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial 2008-10-30

Studies

4 studies carry this tag.

Date range

2006 to 2016

Top journals

  • Annals of neurology 1
  • Journal of neural transmission (Vienna, Austria : 1996) 1
  • Neurology 1
  • Scientific reports 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Scientific reports 2016-10-17 Mild cognitive impairment

    Quantitative Susceptibility Mapping (QSM) MRI at 7 Tesla and 11-Carbon Pittsburgh-Compound-B PET were used for investigating the relationship between brain iron and Amyloid beta (Aβ) plaque-load in a context of increased risk for Alzheimer's disease (AD), as reflected by the Apolipoprotein E ε4 (APOE-e4) allele and mild cognitive impairment (MCI) in elderly subjects.

  2. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Annals of neurology 2014-04-14 Genetics

    Among the evaluated parameters, the only significant predictor of conversion to AD was non-Cp copper (hazard ratio = 1.23, 95% confidence interval = 1.03-1.47, p = 0.022); for each additional micromole per liter unit (μmol/l) of non-Cp copper, the hazard increased by ~20%.

  3. Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Journal of neural transmission (Vienna, Austria : 1996) 2008-10-30 Treatments

    A plethora of reports suggest that copper (Cu) homeostasis is disturbed in Alzheimer's disease (AD).

  4. Elevated cortical zinc in Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2006-07-01 Caregiving

    Brain zinc accumulation is a prominent feature of advanced Alzheimer disease (AD) and is biochemically linked to brain amyloid beta-peptide accumulation and dementia severity in AD.

All topic tags with their study counts